Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer
Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer
Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
14: Sudbo J. [Chemoprevention of oral cancer] Tidsskr Nor Laegeforen. 2003 May<br />
29;123(11):1518-21. Review. Norwegian.<br />
15: Sudbo J. [Chemoprevention: treatment of persons at high risk of cancer] Tidsskr Nor<br />
Laegeforen. 2003 May 29;123(11):1514-7. Review. Norwegian.<br />
16: Sudbo J, Ristimaki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B,<br />
Nesland JM, Bryne M. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral<br />
lesions. Oral Oncol. 2003 Jul;39(5):497-505.<br />
17: Scully C, Sudbo J, Speight PM. Progress in determining the malignant potential of oral<br />
lesions. J Oral Pathol Med. 2003 May;32(5):251-6. Review.<br />
18: Sudbo J, Reith A. When is an oral leukoplakia premalignant?<br />
Oral Oncol. 2002 <strong>De</strong>c;38(8):813-4; author reply 811-2. No abstract available.<br />
19: Sudbo J, Reith A. Which putatively pre-malignant oral lesions become oral cancers? Clinical<br />
relevance of early targeting of high-risk individuals.<br />
J Oral Pathol Med. 2003 Feb;32(2):63-70. Review.<br />
20: Reith A, Sudbo J. Impact of genomic instability in risk assessment and chemoprevention of<br />
oral premalignancies. Int J Cancer. 2002 Sep 20;101(3):205-9. Review.<br />
21: Sudbo J. [Adverse effects of COX-2 inhibitors] Tidsskr Nor Laegeforen. 2002 Jan<br />
10;122(1):102-3. Norwegian.<br />
22: Sudbo J. [DNA ploidy analysis--a possibility for early identification of patient with risk of<br />
oral cancer] Lakartidningen. 2001 Nov 7;98(45):4980-4. Review. Norwegian.<br />
23: Sudbo J. Pathology in disgrace? J Pathol. 2002 Feb;196(2):244-5. No abstract available.<br />
24: Sudbo J, Kildal W, Johannessen AC, Koppang HS, Sudbo A, Danielsen HE, Risberg B,<br />
Reith A. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up<br />
study in oral erythroplakias. J Clin Oncol. 2002 Jan 15;20(2):456-62.<br />
25: Sudbo J, Warloe T, Aamdal S, Reith A, Bryne M. [Diagnosis and treatment of oral<br />
precancerous lesions] Tidsskr Nor Laegeforen. 2001 Oct 30;121(26):3066-71. Norwegian.<br />
26: Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A.<br />
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white<br />
patches. Oral Oncol. 2001 Oct;37(7):558-65.<br />
27: Sudbo J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the<br />
head and neck. N Engl J Med. 2001 Aug 2;345(5):376-7.<br />
28: Sudbo J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of<br />
histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral<br />
dysplasia. J Pathol. 2001 Jul;194(3):303-10.<br />
29: Sudbo J, Reith A, Lingjaerde OC. Gene-_expression profiles in hereditary breast cancer. N<br />
Engl J Med. 2001 Jun 28;344(26):2029. No abstract available.<br />
124